These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cancer "Avatars": Patient-Derived Xenograft Growth Correlation with Postoperative Recurrence and Survival in Pancreaticobiliary Cancer. Lynch IT; Abdelrahman AM; Alva-Ruiz R; Fogliati A; Graham RP; Smoot R; Truty MJ J Am Coll Surg; 2023 Sep; 237(3):483-500. PubMed ID: 37326316 [TBL] [Abstract][Full Text] [Related]
6. Establishment of a Liver Transplant Patient-derived Tumor Xenograft (PDX) Model Using Cryopreserved Pancreatic Ductal Adenocarcinoma. Tanaka R; Kageyama K; Kimura K; Eguchi S; Tauchi J; Shinkawa H; Ohira GO; Yamazoe S; Yamamoto A; Tanaka S; Amano R; Tanaka H; Yashiro M; Kubo S; Ohira M Anticancer Res; 2020 May; 40(5):2637-2644. PubMed ID: 32366408 [TBL] [Abstract][Full Text] [Related]
7. Patient Characteristics Associated with Growth of Patient-Derived Tumor Implants in Mice (Patient-Derived Xenografts). Hernández Guerrero T; Baños N; Del Puerto Nevado L; Mahillo-Fernandez I; Doger De-Speville B; Calvo E; Wick M; García-Foncillas J; Moreno V Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001663 [No Abstract] [Full Text] [Related]
8. Surgical and Oncological Factors Affecting the Successful Engraftment of Patient-derived Xenografts in Pancreatic Ductal Adenocarcinoma. Jun E; Jung J; Jeong SY; Choi EK; Kim MB; Lee JS; Hong SM; Seol HS; Hwang C; Hoffman RM; Shim IK; Chang S; Kim SC Anticancer Res; 2016 Feb; 36(2):517-21. PubMed ID: 26851005 [TBL] [Abstract][Full Text] [Related]
9. Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival. Pergolini I; Morales-Oyarvide V; Mino-Kenudson M; Honselmann KC; Rosenbaum MW; Nahar S; Kem M; Ferrone CR; Lillemoe KD; Bardeesy N; Ryan DP; Thayer SP; Warshaw AL; Fernández-Del Castillo C; Liss AS PLoS One; 2017; 12(8):e0182855. PubMed ID: 28854237 [TBL] [Abstract][Full Text] [Related]
10. Creation and Maintenance of a Living Biobank - How We Do It. Bürtin F; Matschos S; Prall F; Mullins CS; Krohn M; Linnebacher M J Vis Exp; 2021 Apr; (170):. PubMed ID: 33900297 [TBL] [Abstract][Full Text] [Related]
11. Rituximab Decreases Lymphoproliferative Tumor Formation in Hepatopancreaticobiliary and Gastrointestinal Cancer Patient-Derived Xenografts. Leiting JL; Hernandez MC; Yang L; Bergquist JR; Ivanics T; Graham RP; Truty MJ Sci Rep; 2019 Apr; 9(1):5901. PubMed ID: 30976061 [TBL] [Abstract][Full Text] [Related]
12. Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies. William D; Mullins CS; Schneider B; Orthmann A; Lamp N; Krohn M; Hoffmann A; Classen CF; Linnebacher M J Transl Med; 2017 Feb; 15(1):27. PubMed ID: 28183348 [TBL] [Abstract][Full Text] [Related]
13. Patient-derived xenograft cryopreservation and reanimation outcomes are dependent on cryoprotectant type. Ivanics T; Bergquist JR; Liu G; Kim MP; Kang Y; Katz MH; Perez MVR; Thomas RM; Fleming JB; Truty MJ Lab Invest; 2018 Jul; 98(7):947-956. PubMed ID: 29520054 [TBL] [Abstract][Full Text] [Related]
14. Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis. Kageyama K; Ohara M; Saito K; Ozaki S; Terai M; Mastrangelo MJ; Fortina P; Aplin AE; Sato T J Transl Med; 2017 Jun; 15(1):145. PubMed ID: 28645290 [TBL] [Abstract][Full Text] [Related]
15. Patient Derived Xenografts Expand Human Primary Pancreatic Tumor Tissue Availability for Brock RM; Beitel-White N; Coutermarsh-Ott S; Grider DJ; Lorenzo MF; Ringel-Scaia VM; Manuchehrabadi N; Martin RCG; Davalos RV; Allen IC Front Oncol; 2020; 10():843. PubMed ID: 32528898 [TBL] [Abstract][Full Text] [Related]
16. Patient-derived xenograft models for gastrointestinal tumors: A single-center retrospective study. Yu X; Chen Y; Lu J; He K; Chen Y; Ding Y; Jin K; Wang H; Zhang H; Wang H; Teng L Front Oncol; 2022; 12():985154. PubMed ID: 36465411 [TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of patient-derived head and neck cancer models from surgical specimens and endoscopic biopsies. Strüder D; Momper T; Irmscher N; Krause M; Liese J; Schraven S; Zimpfer A; Zonnur S; Burmeister AS; Schneider B; Frerich B; Mlynski R; Große-Thie C; Junghanss C; Maletzki C J Exp Clin Cancer Res; 2021 Aug; 40(1):246. PubMed ID: 34362423 [TBL] [Abstract][Full Text] [Related]
18. Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response. Zhang F; Wang W; Long Y; Liu H; Cheng J; Guo L; Li R; Meng C; Yu S; Zhao Q; Lu S; Wang L; Wang H; Wen D Cancer Commun (Lond); 2018 Sep; 38(1):60. PubMed ID: 30257718 [TBL] [Abstract][Full Text] [Related]
19. Orthotopic Implantation Achieves Better Engraftment and Faster Growth Than Subcutaneous Implantation in Breast Cancer Patient-Derived Xenografts. Okano M; Oshi M; Butash A; Okano I; Saito K; Kawaguchi T; Nagahashi M; Kono K; Ohtake T; Takabe K J Mammary Gland Biol Neoplasia; 2020 Mar; 25(1):27-36. PubMed ID: 32109311 [TBL] [Abstract][Full Text] [Related]
20. Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models. Shin HY; Lee EJ; Yang W; Kim HS; Chung D; Cho H; Kim JH Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]